Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY

Hopcroft LE. et al, (2023), Wellcome Open Research, 8, 70 - 70

A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection.

Calvert C. et al, (2023), Nat Commun, 14

Confirmed SARS-CoV-2 infection in Scottish neonates 2020-2022: a national, population-based cohort study.

Goulding A. et al, (2023), Arch Dis Child Fetal Neonatal Ed

Identifying Patterns of Clinical Interest in Clinicians' Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical Review.

MacKenna B. et al, (2022), JMIR Med Inform, 10

A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection

Calvert C. et al, (2022), Nature Communications, 13

Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY

Green A. et al, (2022), BMC Medicine, 20

Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study

Stock SJ. et al, (2022), The Lancet. Respiratory medicine, 10, 1129 - 1136

Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication Therapy

Gómez-Castañeda E. et al, (2022), Cancers, 14

Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records

Horne EMF. et al, (2022), BMJ (Clinical research ed.), 378

Effectiveness of BNT162b2 booster doses in England: an observational study in OpenSAFELY-TPP

Hulme W. et al, (2022)

Changes in English medication safety indicators throughout the COVID-19 pandemic: a federated analysis of 57 million patients’ primary care records in situ using OpenSAFELY

Fisher L. et al, (2022)

Waning effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines over six months since second dose: a cohort study using linked electronic health records

Horne EMF. et al, (2022)

Trends, variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY

The OpenSAFELY Collaborative None. et al, (2022)

SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland

Stock SJ. et al, (2022), Nature Medicine

A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)

Stewart GD. et al, (2022), British Journal of Cancer

Author Correction: SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland (Nature Medicine, (2022), 10.1038/s41591-021-01666-2)

Stock SJ. et al, (2022), Nature Medicine

Data-driven identification of unusual prescribing behaviour: an analysis and interactive data tool using six months of primary care data from 6500 practices in England

Hopcroft LEM. et al, (2022)

Eleven key measures for monitoring general practice clinical activity during COVID-19 using federated analytics on 48 million adults' primary care records through OpenSAFELY

Fisher L. et al, (2022)

Tyrosine kinase inhibitor independent gene expression signature in CML offers new targets for LSPC eradication therapy

Gómez-Castañeda E. et al, (2022)

Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: A cohort study from OpenSAFELY

The OpenSAFELY Collaborative: None. et al, (2021)

Load More